Skip to content

About Us
- Management
- History
Our Focus Area
- Innovative Drugs
- Ophthalmic Diagnostic Device
Media
Investors
- Financial Reports
- Shareholder Information
  - Shareholder Structure
  - Shareholder Meeting
Partnering
Contact Us
English
- Chinese (Traditional)
Search for:

About Us
- Management
- History
Our Focus Area
- Innovative Drugs
- Ophthalmic Diagnostic Device
Media
Investors
- Financial Reports
- Shareholder Information
  - Shareholder Structure
  - Shareholder Meeting
Partnering
Contact Us
English
- Chinese (Traditional)
Search for:

About Us
- Management
- History
Our Focus Area
- Innovative Drugs
- Ophthalmic Diagnostic Device
Media
Investors
- Financial Reports
- Shareholder Information
  - Shareholder Structure
  - Shareholder Meeting
Partnering
Contact Us
English
- Chinese (Traditional)

Search for:

Home/2010

2010 - 2010

Share on Facebook Share on Twitter Share on LinkedIn Share on Tumblr Share on Google Plus Pin this Share on VK Email this

SB01 approved for phase 1 clinical trial by FDA and TFDA.

Next article

Previous article

Phone: +886-2-2760-3688
Fax: +886-2-2763-9287

Taipei Office:
4F, No.69, DongXing Rd., XinYi Dist., Taipei City 110, Taiwan

About Us

Leadership
History

Focus Area

Innovative Drugs
Ophthalmic Diagnostic Device

Media

News
Events
Knowledge

Investor

Investors
Financial Reports
Shareholder Information

Partnering

Contact Us
Partnering
Join Us

Copyright© 2018 杏國新藥股份有限公司 | 網頁設計公司：振作國際